Atlas Trials

Exemestane and Cyclophosphamide for Metastatic Breast Cancer

Clinical trial NCT01963481 · COMPLETED

Trial details

NCT number
NCT01963481
Sponsor
NYU Langone Health
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Beast Cancer
Start date
2013-09-01
Primary completion
2017-10-01
Enrollment
23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.